share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Arbuckle Stuart A

SEC announcement ·  Feb 27 16:45
Summary by Moomoo AI
Stuart A Arbuckle, EVP and COO of Vertex Pharmaceuticals Inc. (VRTX), completed the sale of 9,748 shares of common stock in two separate transactions. On February 23, 2024, Arbuckle disposed of 4,714 shares at a price of $431.79 per share. Following this transaction, he sold an additional 5,034 shares on February 26, 2024, at a price of $425.7 each. After these transactions, Arbuckle's direct holdings in Vertex Pharmaceuticals totaled 49,691 shares. The total market value of the disposed shares amounted to approximately $4,178,431.86. Additionally, Arbuckle holds 140 shares indirectly through a 401(k) plan.
Stuart A Arbuckle, EVP and COO of Vertex Pharmaceuticals Inc. (VRTX), completed the sale of 9,748 shares of common stock in two separate transactions. On February 23, 2024, Arbuckle disposed of 4,714 shares at a price of $431.79 per share. Following this transaction, he sold an additional 5,034 shares on February 26, 2024, at a price of $425.7 each. After these transactions, Arbuckle's direct holdings in Vertex Pharmaceuticals totaled 49,691 shares. The total market value of the disposed shares amounted to approximately $4,178,431.86. Additionally, Arbuckle holds 140 shares indirectly through a 401(k) plan.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more